Skip to main content
CRISPR Therapeutics AG logo

CRISPR Therapeutics AG — Investor Relations & Filings

Ticker · CRSP ISIN · CH0334081137 LEI · 506700O6IRRIQLT3W370 US Manufacturing
Open in API
Filings indexed 823 across all filing types
Latest filing 2016-09-09 Regulatory Filings
Country CH Switzerland
Listing US CRSP

About CRISPR Therapeutics AG

https://crisprtx.com/

CRISPR Therapeutics AG is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. The company leverages this technology to make precise, directed changes to genomic DNA. As a pioneer in the field, CRISPR Therapeutics has established a diverse portfolio of therapeutic programs across several disease areas, including hemoglobinopathies (such as sickle cell disease and beta-thalassemia), immuno-oncology, regenerative medicine, and cardiovascular disease. The company was one of the first to advance a CRISPR-based therapy into clinical trials and receive regulatory approval, aiming to create potentially curative treatments for patients.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a detailed letter addressed to the U.S. Securities and Exchange Commission regarding a Registration Statement on Form S-1 for CRISPR Therapeutics AG. It discusses the preliminary price range for the company's initial public offering (IPO), stock splits, equity awards, and valuation methodologies. The content is focused on the IPO process, equity valuation, and related financial disclosures. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement or certification. It is a regulatory filing related to the registration and offering process, providing detailed supplemental information to the SEC. Given the nature of the document as a correspondence supplementing a registration statement and discussing IPO pricing and equity awards, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not neatly fit into other categories but are regulatory in nature and related to SEC filings.
2016-09-09 English
S-1
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC). It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of common shares by CRISPR Therapeutics AG. The text includes detailed information typical of an S-1 filing such as the offering details, risk factors, business overview, management discussion, financial data, and underwriting information. This type of document is a regulatory filing used to register securities for public sale and is not an annual report, earnings release, or any other report type. It is a comprehensive disclosure document required before a company goes public. Therefore, the appropriate classification is Regulatory Filings (RNS), which covers miscellaneous SEC filings that do not fit other categories, including registration statements like Form S-1.
2016-09-09 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from a company's legal counsel to the SEC regarding comments on an Amendment No. 4 to a Draft Registration Statement on Form S-1. The content focuses on accounting treatments and interpretations related to convertible loans and financial instruments, referencing authoritative accounting literature and standards (ASC 480, Statement 150, etc.). It is not a financial report itself but a regulatory correspondence addressing SEC staff comments on a registration statement draft. The document is lengthy (15,000 characters) and contains detailed technical explanations but does not present financial statements or results. It is not an announcement of a report but a regulatory filing responding to SEC comments. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2016-09-02 English
Regulatory Filings 2016
Regulatory Filings
2016-08-26 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC, as indicated by the header and references to the Securities Act of 1933. It includes detailed information about the registration of securities, indemnification of directors and officers, recent sales of unregistered securities, and exhibits. The document is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an earnings release or a call transcript. It is a regulatory filing related to the registration of securities for an initial public offering or other public offering. The document is lengthy (15,000 characters) and contains substantive content typical of a registration statement. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and filings that do not fit other specific categories.
2016-08-19 English
Capital/Financing Update 2016
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC, dated August 12, 2016, for CRISPR Therapeutics AG. It is a preliminary prospectus for an initial public offering (IPO) of common shares. The text includes detailed information typical of an IPO registration statement, such as offering details, risk factors, business overview, management discussion, financial data summaries, and underwriting information. This type of filing is related to capital raising and securities registration rather than a financial report, earnings release, or management discussion. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). Since this is a registration statement for an IPO, it is best classified as a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Therefore, the appropriate classification is CAP with high confidence.
2016-08-12 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.